<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>First-line medications used to treat tobacco dependence in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">First-line medications used to treat tobacco dependence in adults</h1>
<div class="graphic"><div class="figure"><div class="ttl">First-line medications used to treat tobacco dependence in adults</div><div class="cntnt"><table cellspacing="0"><colgroup width="13%"></colgroup> <colgroup width="9%"></colgroup> <colgroup span="6" width="13%"></colgroup> <tbody> <tr> <td class="subtitle1">Drug</td> <td class="subtitle1">OTC? (United States)</td> <td class="subtitle1">Dosing</td> <td class="subtitle1">Administration*</td> <td class="subtitle1">Common adverse effects</td> <td class="subtitle1">Advantages</td> <td class="subtitle1">Disadvantages and precautions</td> <td class="subtitle1">Other notes</td> </tr> <tr class="divider_bottom"> <td>Nicotine patch</td> <td class="centered">Yes</td> <td> <p>21 mg for &gt;10 cigarettes/day</p> <p>14 mg for ≤10 cigarettes/day</p> </td> <td> <p>Apply 1 new patch daily</p> <p>May start patch before quit date</p> <p>Rotate application site</p> <p>Tapering dose is not required</p> </td> <td>Skin irritation, insomnia, vivid dreams</td> <td> <p>Provides steady nicotine level</p> Easiest nicotine product to use</td> <td>User cannot alter nicotine level in case of craving</td> <td>If removed before bedtime, takes 30 minutes to 3 hours after reapplication to reach effective levels</td> </tr> <tr class="divider_bottom"> <td>Nicotine gum</td> <td class="centered">Yes</td> <td> <p>2 mg if first cigarette ≥ 30 minutes after waking</p> 4 mg if first cigarette &lt;30 minutes after waking</td> <td> <p>1 piece every hour as needed</p> <p>Maximum: ≤24 pieces/day</p> No food or drink for 30 minutes before and during use</td> <td>Mouth irritation, jaw soreness, heartburn, hiccups, or nausea (gastrointestinal side effects usually due to overly vigorous chewing)</td> <td> <p>User controls nicotine dose</p> Oral substitute for cigarettes</td> <td> <p>Unpleasant taste</p> <p>Can damage dental work</p> Difficult for denture wearers to use</td> <td>Proper chewing technique required ("chew and park")</td> </tr> <tr class="divider_bottom"> <td>Nicotine lozenge</td> <td class="centered">Yes</td> <td> <p>2 mg if first cigarette ≥30 minutes after waking</p> 4 mg if first cigarette &lt;30 minutes after waking</td> <td> <p>1 piece every 1 to 2 hours as needed</p> Maximum: <ul class="decimal_heading"> <li>5 lozenges/6 hours</li> <li> <p>20 lozenges/day</p> </li> </ul> No food or drink for 30 minutes before and during use</td> <td>Mouth irritation, hiccups, heartburn, or nausea</td> <td> <p>User controls nicotine dose</p> <p>Oral substitute for cigarettes</p> Can be used by smokers with poor dentition or dentures</td> <td>Unpleasant taste</td> <td> </td> </tr> <tr class="divider_bottom"> <td>Nicotine inhaler</td> <td class="centered">No</td> <td>10 mg per cartridge</td> <td> <p>Inhale as needed (eg, every 1 to 2 hours)</p> Maximum: 16 cartridges/day</td> <td>Mouth and throat irritation</td> <td> <p>User controls nicotine dose</p> Oral substitute for cigarettes</td> <td> <p>Device visible when being used</p> Use caution in reactive airway disease</td> <td>Frequent puffing required to obtain adequate nicotine delivery</td> </tr> <tr class="divider_bottom"> <td>Nicotine nasal spray</td> <td class="centered">No</td> <td>0.5 mg per spray (10 mg/mL)</td> <td> <p>Apply 1 spray to each nostril every 1 to 2 hours as needed</p> Maximum: <ul class="decimal_heading"> <li>10 sprays/hour</li> <li>80 sprays/day</li> </ul> </td> <td>Nasal and throat irritation, rhinitis, sneezing, cough, or teary eyes</td> <td> <p>User controls nicotine dose</p> Most rapid delivery of nicotine among nicotine-replacement products</td> <td>Local irritation to nasal mucosa is difficult for many to tolerate</td> <td> </td> </tr> <tr class="divider_bottom"> <td>Varenicline</td> <td class="centered">No</td> <td>0.5 mg pill to start, then titrate up to 1 mg pill</td> <td> <p>0.5 mg/day for 3 days, then 0.5 mg twice a day for 4 days, then 1 mg twice a day</p> <p>Start 1 to 2 weeks before quit date</p> <p>May be started up to 5 weeks prior to quit date</p> Abruptly quitting smoking is preferred. Gradual smoking reduction is an alternative: reduce smoking by 50% by week 4, another 50% by week 8, quit by week 12</td> <td>Nausea, insomnia, abnormal (vivid, unusual, or strange) dreams, headache, skin rash (≤3%)</td> <td> <p>Dual action: relieves nicotine withdrawal and blocks reward from smoking</p> Oral agent (pill)</td> <td> <p>Reduced dose in severe renal insufficiency</p> <p>Avoid in patients with unstable psychiatric status or history of suicidal ideation or PTSD</p> Monitor for neuropsychiatric symptoms<sup>¶</sup></td> <td> </td> </tr> <tr> <td>Bupropion sustained release</td> <td class="centered">No</td> <td>150 mg pill</td> <td> <p>150 mg/day for 3 days, then 150 mg twice a day</p> <p>Start 1 to 2 weeks before quit date</p> Abruptly quitting smoking is preferred. Gradual smoking reduction is an alternative: reduce smoking by 50% by week 4, another 50% by week 8, quit by week 12</td> <td>Insomnia, agitation, dry mouth, headache</td> <td> <p>Blunts postcessation weight gain while being used</p> Oral agent (pill)</td> <td> <p>Monitor for neuropsychiatric symptoms<sup>¶</sup></p> Contraindicated in patients with seizure disorder or predisposition</td> <td>A lower dose of 150 mg/day is an option for patients who do not tolerate the full dose</td> </tr> </tbody></table></div><div class="graphic_footnotes">OTC: over-the-counter (nonprescription) sale; PTSD: posttraumatic stress disorder; NRT: nicotine replacement therapy.<br/>* All pharmacologic agents may be extended for an additional 12 weeks (or even longer, up to 1 year) if the patient has quit smoking but still feels at risk for relapse based upon experience with prior quit attempts. NRT may be continued indefinitely.<br/>¶ Neuropsychiatric symptoms include: behavioral changes, hostility, agitation, depressed mood, suicidal ideation and attempts.</div><div class="graphic_reference">References:

	<ol>
<li>Rigotti NA. Strategies to help a smoker who is struggling to quit. JAMA 2012; 308:1573.</li>
<li>Shahab L, Brose LS, West R. Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: Rationale, and evidence for advantages over existing systems. CNS Drugs 2013; 27:10079</li>
</ol></div><div id="graphicVersion">Graphic 97259 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
